NASDAQ | ETF
The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser.
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 7.40% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 7.07% |
| RDNT | RadNet Inc | Healthcare | Diagnostics & Research | 6.50% |
| TMDX | TransMedics Group Inc | Healthcare | Medical Devices | 6.39% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 6.21% |
| LIVN | LivaNova PLC | Healthcare | Medical Devices | 6.17% |
| MMSI | Merit Medical Systems Inc | Healthcare | Medical Instruments & Supplies | 5.00% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 4.42% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| ETNB | 89bio Inc | Healthcare | Biotechnology | 4.19% |
| ATEC | Alphatec Holdings Inc | Healthcare | Medical Devices | 4.08% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 4.07% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 3.62% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.16% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 3.15% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.14% |
| WVE | Wave Life Sciences Ltd | Healthcare | Biotechnology | 2.90% |
| KALV | Kalvista Pharmaceuticals Inc | Healthcare | Biotechnology | 2.83% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 2.80% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 2.43% |